Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TOMM20P3 is a processed pseudogene of the human TOMM20 gene, sharing 96.2% similarity with the coding TOMM20 (translocase of outer mitochondrial membrane 20) cDNA but is 5' and 3' truncated and is non-functional as a protein-coding gene. Like other processed pseudogenes, it likely arose via reverse transcription of mRNA and integration into the genome at a new location. TOMM20P3 does not code for a functional TOMM20 protein and there is no evidence that it has a biological role or therapeutic relevance. The parent TOMM20 gene encodes a mitochondrial protein import receptor, but TOMM20P3 itself is not a target for drugs, is not a receptor, and is not implicated in human diseases[2]. TOMM20P3 is distinct from the functional TOMM20 gene. TOMM20P3 is a processed, noncoding pseudogene, not a protein[2]. There are no known drugs, mechanisms of action, or disease associations for TOMM20P3. Only its parent gene, TOMM20, is involved in mitochondrial protein import and has disease links—not TOMM20P3[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translocase of outer mitochondrial membrane 20 homolog pseudogene 3 (TOMM20P3).